未登录

Y

Yao-Wu Liu

Xuzhou Medical University

H指数:30

被引数:2,438

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

TAS2R46 activation protects intestinal barrier from chronic high glucose

TAS2R46的激活保护肠道屏障免受慢性高血糖的影响

brain, behavior, and immunity

IF0

2026-02-240

PRE

Changes in neurotransmitter metabolic profiles in copper-loaded rats as assessed by mass spectrometry imaging and the effect of Gandouling intervention

通过质谱成像评估铜负荷大鼠神经递质代谢谱的变化及甘豆灵干预的影响

Experimental Neurology

IF4.2

2025-09-090

PRE

Activation of bitter taste receptor TAS2R4 alleviates diabetic nephropathy in mice

TAS2R4苦味受体的激活缓解小鼠糖尿病肾病

BIOCHEMICAL PHARMACOLOGY

IF5.6

2025-07-010

PRE

Lactate-triggered histone lactylation contributes to podocyte epithelial-mesenchymal transition in diabetic nephropathy in mice

乳酸触发的组蛋白乳酸化对小鼠糖尿病肾病足细胞上皮-间质转化有贡献

CHEMICO-BIOLOGICAL INTERACTIONS

IF5.4

2025-02-011

PRE

Activation of TAS2R4 signaling attenuates podocyte injury induced by high glucose

BIOCHEMICAL PHARMACOLOGY

IF5.6

2024-08-013

PRE

Numerical investigation of river blocking process of Gangda paleolandslide at the upstream reaches of the Jinsha River, Tibentan Plateau

铁本滩高原金沙江上游港大古滑坡阻流过程的数值研究

IF7

2023-05-253

PRE

Relationship between epicardial adipose tissue measured by computed tomography and premature ventricular complexes originating from different sites

IF7.4

2023-04-214

OAAI

Piperine, as a TAS2R14 agonist, stimulates the secretion of glucagon-like peptide-1 in the human enteroendocrine cell line Caco-2

FOOD & FUNCTION

IF5.4

2022-01-017

PRE

Lack of miRNA-17 family mediates high glucose-induced PAR-1 upregulation in glomerular mesangial cells

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

IF3.1

2021-11-181

PRE

Sarsasapogenin restores podocyte autophagy in diabetic nephropathy by targeting GSK3β signaling pathway

BIOCHEMICAL PHARMACOLOGY

IF5.6

2021-10-0139

PRE

Sarsasapogenin attenuates Alzheimer-like encephalopathy in diabetes

IF8.3

2021-10-0114

PREAI

Hesperetin ameliorates diabetes-associated anxiety and depression-like behaviors in rats via activating Nrf2/ARE pathway

METABOLIC BRAIN DISEASE

IF3.5

2021-07-1732

PRE

Sarsasapogenin alleviates diabetic nephropathy through suppression of chronic inflammation by down-regulating PAR-1: In vivo and in vitro study

IF8.3

2020-11-0125

PREAI

Thrombin/PAR-1 activation induces endothelial damages via NLRP1 inflammasome in gestational diabetes

凝血酶/PAR-1激活通过NLRP1炎性小体诱导妊娠期糖尿病内皮损伤

BIOCHEMICAL PHARMACOLOGY

IF5.6

2020-05-0125

PREAI

Protective effects of sarsasapogenin against early stage of diabetic nephropathy in rats (vol 32, pg 1574, 2018)

PHYTOTHERAPY RESEARCH

IF6.3

2019-07-157

OAAI

Hesperetin ameliorates diabetic nephropathy in rats by activating Nrf2/ ARE/glyoxalase 1 pathway

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2019-03-01102

OAAI

Neuroprotection of quercetin on central neurons against chronic high glucose through enhancement of Nrf2/ARE/glyoxalase-1 pathway mediated by phosphorylation regulation

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2019-01-0169

OAAI

Enhancement of glyoxalase 1, a polyfunctional defense enzyme, by quercetin in the brain in streptozotocin-induced diabetic rats

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

IF3.1

2018-07-3028

PREAI

Protective effects of sarsasapogenin against early stage of diabetic nephropathy in rats

PHYTOTHERAPY RESEARCH

IF6.3

2018-04-2355

PREAI

Sarsasapogenin suppresses Aβ overproduction induced by high glucose in HT-22 cells

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

IF3.1

2017-12-2311

PREAI